Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

Condition:   Asthma
Intervention:   Drug: salbutamol sulfate + ipratropium bromide
Sponsor:   Boehringer Ingelheim
Terminated – verified July 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.